Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  GlaxoSmithKline plc    GS7   GB0009252882

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo GlaxoSmithKline plc
Develops, manufactures and distributes vaccines and other pharmaceutical products

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.

It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.

The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.

The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.

The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.

The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Managers
NameAgeSinceTitle
Andrew Witty522008Chief Executive Officer & Executive Director
Philip Hampton532015Non-Executive Chairman
Simon Dingemans532011Chief Financial Officer & Executive Director
Birgitte Volck MD, PhD552016Head-Research & Development
Moncef Slaoui, PhD562006Executive Director & Chairman-Global Vaccines
Roy Malcolm Anderson692007Independent Non-Executive Director
Patrick J. T. Vallance, MD-2006Executive Director
Judy Carol Lewent682011Independent Non-Executive Director
Emma Walmsley-2010CEO-Designate & Executive Director
Lynn Laverty Elsenhans, MBA602012Independent Non-Executive Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 5,368,593,922 4,862,660,655 90.6% 458,200,000 8.5% 90.6%
Shareholders
NameEquities%
BlackRock Investment Management (UK) Ltd. 207,257,650 4.22%
Legal & General Investment Management Ltd. 147,931,457 3.01%
The Vanguard Group, Inc. 119,362,633 2.43%
Capital Research & Management Co. (Global Investors) 93,086,263 1.90%
Norges Bank Investment Management 92,073,000 1.88%
Woodford Investment Management LLP 65,812,842 1.34%
State Street Global Advisors Ltd. 63,747,845 1.30%
Schroder Investment Management Ltd. 56,896,951 1.16%
Threadneedle Asset Management Ltd. 56,696,764 1.15%
Capital Research & Management Co. (World Investors) 56,363,225 1.15%
Holdings
NameEquities%Valuation
Innoviva Inc (INVA) 32,005,26029.4%339,255,756 USD
Theravance Biopharma Inc (TBPH) 9,644,80718.6%288,958,418 USD
JCR Pharmaceuticals Co Ltd (4552) 7,986,00024.6%186,996,183 USD
Crispr Therapeutics AG (CRSP) 3,220,6278.09%57,166,129 USD
Dong-A Socio Holdings Co Ltd (000640) 409,6936.77%44,244,447 USD
GlaxoSmithKline S.A.E. 76,161,37891.2%38,864,390 USD
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 444,065,54137.1%22,314,293 USD
Oncomed Pharmaceuticals Inc (OMED) 2,607,5467.03%21,538,330 USD
Allergy Therapeutics plc (AGY) 10,118,0001.70%3,293,713 USD
SCYNEXIS Inc (SCYX) 545,0062.27%1,645,918 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
GLAXOSMITHKLINE PLC7.00%100 913
JOHNSON & JOHNSON3.86%325 539
ROCHE HOLDING LTD.4.90%212 000
PFIZER INC.3.51%204 018
NOVARTIS AG3.51%202 892
MERCK & CO., INC.11.23%180 537
SANOFI4.72%109 519
GLAXOSMITHKLINE PLC4.96%100 913
BAYER AG9.86%94 791
ALLERGAN PLC17.69%92 705
BRISTOL-MYERS SQUIBB C..-6.26%91 550
ELI LILLY AND CO9.26%88 713
ABBOTT LABORATORIES17.18%77 777
ASTRAZENECA PLC3.55%71 921
NOVO NORDISK A/S-3.02%71 178
SHIRE PLC2.70%54 221
TEVA PHARMACEUTICAL IN..0.58%37 604
TAKEDA PHARMACEUTICAL ..8.91%36 687
ASTELLAS PHARMA INC-7.41%28 580
MYLAN NV10.88%22 635
CHUGAI PHARMACEUTICAL ..15.95%19 190
Sector Pharmaceuticals - NEC
GlaxoSmithKline plc : Connections
Pearson Education Ltd.
Business Council for Britain
Pharmaceutical Research & Manufacturers of America
American Academy of Arts & Sciences
The Council for Industry & Higher Education
European Federation of Pharmaceutical Industries & Assns
The 100 Group
The University of Nottingham
National Theatre of Scotland
Sunoco Chemicals, Inc.
TFS Trial Form Support AB
Central Houston, Inc.
Office for Strategic Co-ordination of Health Research
French Academy of Sciences
GlaxoSmithKline, Inc.
Genome Research Ltd.
Biotechnology Innovation Organization
Glaxosmithkline Australia Pty Ltd.
United Kingdom Department for Business, Innovation & Skills
Rockefeller Family Trust, Inc.
United Way of Greater Houston
Massachusetts Institute of Technology
World Golf Foundation, Inc.
Sunoco Partners LLC
International AIDS Vaccine Initiative, Inc.
PhRMA Foundation
Longwood Fund Management LLC
Rice University
The Natural History Museum
The Texas Medical Center
Institute of Medicine
The First Tee of Greater Houston
Company contact information
980 Great West road
TW8 9GS Brentford, Greater London
United Kingdom

Phone : +44 (0)20 8047 5000
Fax : +44 (0)20 8047 7807
Internet : http://www.gsk.com
Markets and indexes
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
Stock Exchange Codes
- ISIN Code :  GB0009252882
- Bloomberg Code :  GSK:LN
- Reuters Code :  GSK.L
- Datastream Code :  GSK
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem